Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giacomo S Frattari

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Vaccine|October 15, 2025
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targetsEmma Falling Iversen, Anna H F Rahimic, Giacomo S Frattari, et al.
Iscience|September 4, 2023
Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1Lamin B Cham, Jesper D Gunst, Mariane H Schleimann, et al.
Ebiomedicine|June 7, 2021
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severityStine Sf Nielsen, Line K Vibholm, Ida Monrad, et al.
Ebiomedicine|February 2, 2021
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responsesLine K Vibholm, Stine S F Nielsen, Marie H Pahus, et al.
Clinical and Experimental Immunology|April 10, 2026
Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised PatientsIda M Johannsen, Line K Vibholm, Giacomo S Frattari, et al.
Eclinicalmedicine|April 27, 2021
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trialJesper D Gunst, Nina B Staerke, Marie H Pahus, et al.
Nature Immunology|March 3, 2026
Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention controlKatie Fisher, Mauro A Garcia, Giacomo S Frattari, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Vaccine|October 15, 2025
TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targetsEmma Falling Iversen, Anna H F Rahimic, Giacomo S Frattari, et al.
Iscience|September 4, 2023
Single cell analysis reveals a subset of cytotoxic-like plasmacytoid dendritic cells in people with HIV-1Lamin B Cham, Jesper D Gunst, Mariane H Schleimann, et al.
Ebiomedicine|June 7, 2021
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severityStine Sf Nielsen, Line K Vibholm, Ida Monrad, et al.
Ebiomedicine|February 2, 2021
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responsesLine K Vibholm, Stine S F Nielsen, Marie H Pahus, et al.
Clinical and Experimental Immunology|April 10, 2026
Immunological Dysfunction Associated with SARS-CoV-2 Persistence in Immunocompromised PatientsIda M Johannsen, Line K Vibholm, Giacomo S Frattari, et al.
Eclinicalmedicine|April 27, 2021
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trialJesper D Gunst, Nina B Staerke, Marie H Pahus, et al.
Nature Immunology|March 3, 2026
Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention controlKatie Fisher, Mauro A Garcia, Giacomo S Frattari, et al.
Pageof 1